Hawkins, Inc. (NASDAQ:HWKN – Get Free Report) VP Drew Grahek acquired 1,587 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were acquired at an average cost of $126.34 per share, for a total transaction of $200,501.58. Following the completion of the acquisition, the vice president owned 39,640 shares of the company’s stock, valued at approximately $5,008,117.60. The trade was a 4.17% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Hawkins Stock Performance
NASDAQ:HWKN opened at $127.91 on Friday. The stock has a market cap of $2.67 billion, a P/E ratio of 32.14, a PEG ratio of 2.25 and a beta of 0.82. Hawkins, Inc. has a twelve month low of $98.30 and a twelve month high of $186.15. The business’s 50-day moving average price is $166.36 and its two-hundred day moving average price is $152.87. The company has a quick ratio of 1.45, a current ratio of 2.31 and a debt-to-equity ratio of 0.59.
Hawkins (NASDAQ:HWKN – Get Free Report) last posted its earnings results on Wednesday, October 29th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.24 by ($0.16). Hawkins had a return on equity of 17.79% and a net margin of 7.95%.The business had revenue of $280.43 million during the quarter, compared to the consensus estimate of $284.42 million. As a group, equities analysts predict that Hawkins, Inc. will post 4 EPS for the current fiscal year.
Hawkins Announces Dividend
Analyst Upgrades and Downgrades
Several research analysts have weighed in on the company. Zacks Research downgraded Hawkins from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Hawkins in a report on Tuesday, October 14th. Raymond James Financial assumed coverage on shares of Hawkins in a report on Thursday, July 24th. They set a “market perform” rating on the stock. Finally, BWS Financial restated a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a report on Monday, November 3rd. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Hawkins presently has a consensus rating of “Hold” and an average target price of $162.50.
View Our Latest Report on Hawkins
Institutional Investors Weigh In On Hawkins
Hedge funds have recently modified their holdings of the company. Salomon & Ludwin LLC acquired a new stake in Hawkins during the 3rd quarter valued at $27,000. Brooklyn Investment Group grew its position in Hawkins by 533.3% in the first quarter. Brooklyn Investment Group now owns 266 shares of the specialty chemicals company’s stock worth $28,000 after buying an additional 224 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Hawkins by 118.8% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 280 shares of the specialty chemicals company’s stock valued at $30,000 after buying an additional 152 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in Hawkins in the 2nd quarter worth about $31,000. Finally, First Horizon Corp purchased a new stake in shares of Hawkins in the 3rd quarter valued at approximately $34,000. 69.71% of the stock is owned by institutional investors and hedge funds.
About Hawkins
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
See Also
- Five stocks we like better than Hawkins
- Stock Dividend Cuts Happen Are You Ready?
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- How to Invest in Blue Chip Stocks
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
